Abstract
New and Noteworthy
Introduction more susceptible to heart failure(4). PGC-1α does not bind to DNA directly, and requires (Invitorgen) following manufacturer's instructions and subjected to reverse transcription using High Capacity Reverse Transcription (Invitrogen). Quantitative real-time PCR was 129 performed on cDNA using the intercalating fluorescent dye SYBR green (BioRad) with 130 gene specific primers using a CFX 384 Touch real-time PCR machine (BioRad). Relative 131 expression was determined using the Comparative cycle threshold method (2 -∆∆Ct ) with 132 36B4, HPRT and TBP used as housekeeping genes. For human samples used for gene 133 expression studies, whole human hearts were procured from two separate patient 134 groups: patients with end-stage heart failure who received heart transplants and hearts 135 from brain dead organ donors. The failing hearts (dilated CM n=13 and ischemic CM 136 n=13) came from patients undergoing transplants at the University of Pennsylvania.
137
Hearts from brain-dead organ donors were made available through the Gift of Life Donor evidence of significant myocardial pathology (non-failing controls n=13). Tissue from 140 age-matched individuals with no pathological or clinical evidence of heart disease were 141 subjected to the same protocol and used as controls.
142
Complex IV and Citrate synthase enzymatic activity. Heart samples were snap frozen 143 with liquid nitrogen until ready to process. Complex IV activity was measured by from the ratio of bound to unbound Fura2-AM. These measurements were used to determine contractile and calcium transients depicting the cell's overall contractility or 155 the flux of calcium across the cell membrane. Both contractility measurements and 156 calcium transients were recorded for 5-10 minutes, at which point each curve was 
194
We sought to identify transcription factors that were differentially expressed in striated 195 muscle beds of high versus low oxidative capacity. We utilized a high throughput screen
196
in which the expression of ~2000 known or putative transcription factors are screened by 197 qPCR (17, 18, 38) . We compared the expression of the TFs in murine muscle or cells in tissues. qPCR analysis of RNA isolated from various tissues revealed that ESRRβ is 211 most highly expressed in the heart, followed by muscle, kidney, testes, brain, and 212 stomach, all of which are highly oxidative tissues ( Figure 1C ).
214

Cardiac-Specific Deletion of ESRRβ leads to profound adult-onset dilated
ESRRβ is most highly expressed in the heart, yet its role in cardiac physiology is 217 unknown. To determine the role of ESRRβ in the heart we generated a cardiac-specific 
225
ERR β KO had poor survival rates after 9 to 10 months of age as quantified by Kaplanweight ( Figure 2C ) as well as heart weight to tibial length ( Figure 2D ). qPCR analysis of signature in the hearts of the MHC-ERRB KO. Masson's Trichrome staining of the left 233 ventricle revealed a significant increase in fibrosis ( Figure 2F ). This increase in fibrosis 234 was confirmed by qPCR analysis revealing a significant increase in collagen and other 235 fibrotic markers ( Figure 2G ).
236
We next sought to evaluate cardiac function in the MHC-ERRB KO by non- 
266
To evaluate calcium handling in these same cardiomyocytes, we measured 
279
ESRRβ Protein Localization in Human Heart Failure Sections.
We next sought to determine if ESRRβ localization was affected in human heart failure. 
289
Moreover, this localization of ESRRβ was specific, as neither ESRRα (nuclear) ( Figure   290 7B) nor N-cadherin (membrane-bound) revealed any differences in protein distribution
291
( Figure 7C ). Interestingly, in contrast to ESRRα, we did not observe any significant 292 difference in expression of ESRRβ mRNA in cardiac samples from patients with DCM or 293 iCM, compared to donor hearts ( Figure 7D ), indicating that ESRRβ protein expression, 294 stability, or localization is affected post-transcriptionally. Taken together the data 295 indicate that ESRRβ protein is undetectable or mislocalized in human DCM.
297
Discussion
299
The PGC-1s and many of their downstream transcriptional regulators have been 300
shown to be important in maintaining cardiac metabolic function (5, 39, 40 
421
Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR- 
